Key result
Noninvasive cardiovascular imaging provides new technological opportunities for the early evaluation of target organ damage to improve risk stratification in hypertensive patients.
Noninvasive cardiovascular imaging provides technological opportunities for early evaluation of target organ damage, aiding in the risk stratification of hypertensive patients.
Answers are grounded in this paper and cite their sources.
Noninvasive imaging may aid hypertensive risk stratification; leaves open prospective outcome trials before clinical adoption.
: Arterial hypertension accounts for the largest amount of attributable cardiovascular mortality worldwide, and risk stratification in hypertensive patients is of crucial importance to manage treatment and prevent adverse events. Asymptomatic involvement of different organs in patients affected by hypertension represents an independent determinant of cardiovascular risk, and the identification of target organ damage is recommended to further reclassify patients' risk. Noninvasive cardiovascular imaging is progressively being used and continues to provide new technological opportunities to target organ damage evaluation at early stage. The aim of this article is to provide the community of cardiology with an update on appropriate and justified use of noninvasive imaging tests in the growing population of hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Filardi et al. (2017) conducted a review in Arterial hypertension. Noninvasive cardiovascular imaging was evaluated. Noninvasive cardiovascular imaging provides new technological opportunities for the early evaluation of target organ damage to improve risk stratification in hypertensive patients.
Synapse has enriched 10 related papers. Consider them for comparative context: